Foghorn Therapeutics Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.3M | 9.2M | 8.2M | 7.6M | 6.0M | 2.9M | 7.8M | 6.9M |
| Cost of Goods Sold | 238K | 802K | 20.0M | 900K | 0 | 0 | 0 | 0 |
| Gross Profit | 3.0M | 8.4M | -11.8M | 6.7M | 6.0M | 2.9M | 7.8M | 6.9M |
| R&D Expenses | 18.3M | 22.9M | 20.0M | 20.9M | 21.6M | 20.5M | 24.7M | 23.8M |
| Operating Expenses | 24.6M | 28.0M | 6.7M | 27.8M | 28.9M | 26.9M | 31.7M | 33.5M |
| Operating Income | -21.6M | -19.6M | -18.5M | -21.1M | -22.9M | -24.0M | -23.9M | -26.6M |
| Other Income / Gains | 1.7M | -2.1M | 2.7M | 3.2M | 4.1M | 4.5M | 4.7M | 3.7M |
| Net Income | -19.9M | -21.7M | -15.8M | -17.9M | -18.8M | -19.5M | -19.1M | -23.0M |
| EPS (Diluted) | -0.29 | -0.35 | -0.25 | -0.28 | -0.30 | -0.31 | -0.31 | -0.45 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.927 | 0.913 | -1.453 | 0.881 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 6.6M | 6.8M | 6.7M | 6.9M | 7.2M | 6.4M | 7.0M | 7.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.6M | 6.8M | 6.7M | 6.9M | 7.2M | 6.4M | 7.0M | 7.3M |
| Other Expenses | -238K | -1.7M | -20.0M | 0 | 0 | 0 | 0 | 2.4M |
| Cost And Expenses | 24.8M | 28.8M | 26.7M | 28.7M | 28.9M | 26.9M | 31.7M | 33.5M |
| Interest Income | 1.7M | 1.7M | 2.0M | 2.3M | 2.7M | 3.1M | 3.5M | 2.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 238K | 802K | 852K | 900K | 827K | 761K | 733K | 791K |
| Ebitda | -19.6M | -20.9M | -15.0M | -17.0M | -18.0M | -18.7M | -18.4M | -23.4M |
| Ebitdaratio | -6.011 | -2.256 | -1.839 | -2.254 | -3.025 | -6.562 | -2.355 | -3.403 |
| Operating Income Ratio | -6.603 | -2.119 | -2.269 | -2.792 | -3.85 | -8.405 | -3.055 | -3.866 |
| Income Before Tax | -19.9M | -21.7M | -15.8M | -17.9M | -18.8M | -19.5M | -19.1M | -23.0M |
| Income Before Tax Ratio | -6.084 | -2.343 | -1.944 | -2.373 | -3.164 | -6.829 | -2.449 | -3.336 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -6.084 | -2.343 | -1.944 | -2.373 | -3.164 | -6.829 | -2.449 | -3.336 |
| Epsdiluted | -0.29 | -0.35 | -0.25 | -0.28 | -0.30 | -0.31 | -0.31 | -0.45 |
| Weighted Average Shs Out | 69.5M | 63.0M | 63.0M | 63.0M | 62.8M | 62.6M | 62.6M | 51.6M |
| Weighted Average Shs Out Dil | 69.5M | 63.0M | 63.0M | 63.0M | 62.8M | 62.6M | 62.6M | 51.6M |